US Broker Ratings

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a Healthcare Giant with a 1.16% Upside Potential

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a prominent figure in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $8.07 billion, this American-based company..

Illumina, Inc. (ILMN) Stock Analysis: Balancing Innovation in Genomics with Market Volatility

Illumina, Inc. (NASDAQ: ILMN) stands at the forefront of genomic innovation, providing sequencing and array-based solutions that are pivotal for genetic and genomic analysis across the globe. With a market..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth Challenges with Strategic Alliances

Charles River Laboratories International, Inc. (CRL) has long been a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Boasting a market capitalization of $9.07 billion,..

Alcon Inc. (ALC) Stock Analysis: A 16.43% Potential Upside in the Healthcare Sector

Alcon Inc. (NYSE: ALC), a leading player in the healthcare sector, particularly in the medical instruments and supplies industry, presents a compelling opportunity for investors with its robust market presence..

Veeva Systems Inc. (VEEV) Investor Outlook: Unpacking a 58.28% Potential Upside

Veeva Systems Inc. (NYSE: VEEV) stands as a formidable force in the health information services industry, known for its innovative cloud-based solutions catering to the life sciences sector. With a..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Biotech Powerhouse with 8.39% Potential Upside in Precision Oncology

Investors with a keen eye on the biotechnology sector are likely to find Revolution Medicines, Inc. (NASDAQ: RVMD) a compelling prospect. Headquartered in Redwood City, California, this clinical-stage precision oncology..

Hologic, Inc. (HOLX) Stock Analysis: Evaluating the Growth Potential in the Medical Instruments Sector

Hologic, Inc. (NASDAQ: HOLX) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $16.97 billion, Hologic has..

Doximity, Inc. (DOCS) Stock Analysis: Assessing a 54.89% Potential Upside in the Healthcare Sector

Doximity, Inc. (NYSE: DOCS), a leading player in the healthcare information services industry, presents an intriguing opportunity for investors seeking exposure in the digital health sector. With a market capitalization..

Qiagen N.V. (QGEN) Stock Analysis: Unlocking a 30% Upside Potential in the Diagnostics & Research Sector

For investors looking to expand their portfolios in the healthcare sector, Qiagen N.V. (NYSE: QGEN) offers a compelling opportunity with significant growth potential. Headquartered in Venlo, Netherlands, Qiagen is a..

Bio-Techne Corp (TECH) Stock Analysis: Navigating a 22% Potential Upside Amidst Market Dynamics

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its promising potential upside of 22.02%. As a leader in developing..

Incyte Corporation (INCY) Stock Analysis: A Promising Biotech Play with 9.76% Potential Upside

Incyte Corporation (NASDAQ: INCY) continues to capture the attention of investors with its robust portfolio in the biopharmaceutical space. With a market capitalization of $19.47 billion, Incyte is a prominent..

Medtronic plc (MDT) Stock Analysis: Exploring a 26.56% Potential Upside for Investors

As the healthcare landscape continues to evolve, Medtronic plc (MDT) stands out as a key player in the medical devices industry, offering a robust portfolio that spans cardiovascular, neuroscience, medical..

Fresenius Medical Care AG (FMS) Stock Analysis: Potential Upside and Key Investment Insights

Fresenius Medical Care AG (NYSE: FMS), a leading provider of dialysis and related services, has captured the attention of healthcare investors with its expansive global operations and robust market presence...

Masimo Corporation (MASI) Stock Analysis: A Healthcare Beacon with Steady Growth and Innovation

Masimo Corporation (NASDAQ: MASI) stands out in the healthcare sector with its innovative medical devices and patient monitoring technologies. As a key player in the medical devices industry, Masimo has..

Repligen Corporation (RGEN) Stock Analysis: An Insight into its 37.86% Upside Potential

Repligen Corporation (NASDAQ: RGEN) has been garnering attention from investors, and it’s not hard to see why. With a robust market capitalization of $7.4 billion, this Massachusetts-based healthcare company operates..

Merck & Company, Inc. (MRK) Stock Analysis: Navigating a 9% Potential Upside

For investors eyeing the healthcare sector, Merck & Company, Inc. (NYSE: MRK) presents a compelling opportunity. With a solid market capitalization of $294.39 billion, Merck stands as a titan in..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unpacking the 22.67% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is capturing investor interest with its promising growth trajectory and significant potential upside. As a key player in the healthcare sector, specifically within biotechnology, Halozyme..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Strong Buy Ratings Signal Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a leading player in the biotechnology sector, is currently attracting significant attention from investors. With its headquarters in Dublin, Ireland, Jazz Pharmaceuticals is renowned for..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a Potential 29.98% Upside for Investors

The Cooper Companies, Inc. (NYSE: COO) stands as a noteworthy player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $13.67 billion,..

Humana Inc. (HUM) Stock Analysis: Navigating Growth in Healthcare with an Eye on Dividend Yield

Humana Inc. (NYSE: HUM), a prominent player in the healthcare sector, continues to capture investor interest with its diverse offerings and robust growth metrics. As a leading provider of medical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds